Conivaptan

From Ganfyd

Jump to: navigation, search
rINN: Conivaptan
Other Names
YM 087, Vaprisol®
Pharmacological Information
Pharmacology Images
Conivaptan Molecule
Conivaptan.png
Web information on Conivaptan
NHS Evidence on Conivaptan
DrugBank on Conivaptan
Relevant Clinical Literature
Pubmed on Conivaptan
RCT with Conivaptan
Systematic reviews of Conivaptan
Conivaptan in N Eng J Med, Lancet, JAMA, BMJ
Conivaptan in Cochrane Collaboration
TRIP Database on Conivaptan
Google Scholar on Conivaptan
Bandolier on Conivaptan
UK Guidance
Nice Guidance on Conivaptan

BNF-registration required
BNF for children-registration required

UK directory of medicines
UK Medicine Guide (eg pictures of capsules)
Centre for Reviews and Dissemination databases -DARE & NHS EED (evaluates reliability of research)
Prodigy Guidance on Conivaptan
Regulatory Literature
UK SPCs of medicines with marketing authorisation
EMEA search
FDA search
Other Literature
PubChem on Conivaptan
CTD (Comparative Toxicogenomics Database) link
ChemIndustry.com link
Protein Structural Information
Biological Information (GenomeNet)
Protein Knowledgebase (UniProtKB)
Please read pharmacological data limitations
Other Wikis
Medpedia on Conivaptan (Less technical, good quality control)
Wikipedia on Conivaptan (Less technical, ? quality control)

Contents

Introduction

A non-selective angine-vasopressin receptor antagonist (vaptan). Unclear if works in heart failure like more selective agents, as worsening heart failure has been reported[1].

Clinical Use

Indications

  • (FDA) Euvolaemic or hypervolaemic hyponatraemia [2] (secondary to syndrome of inappropriate antidiuretic hormone secretion theoretically but indication stretch seems likely[3]).

Administration

IV

Clinical Issues

Contra-indications

Cautions and Interactions

Side effects

Special advice

Pharmacology

Retrieved from "http://www.ganfyd.org/index.php?title=Conivaptan"
Personal tools